advertisement

---

Fea AM 13

Showing records 1 to 13 | Display all abstracts from Fea AM

104590 Outcomes of XEN 63 Device at 18-Month Follow-Up in Glaucoma Patients: A Two-Center Retrospective Study
Fea AM
Journal of clinical medicine 2022; 11:

---

105026 Glaucoma Treatment and Hydrogel: Current Insights and State of the Art
Fea AM
Gels (Basel, Switzerland) 2022; 8:

---

104348 The current use of glaucoma virtual clinics in Europe
Azzopardi M; Prokosch-Willing V
Eye 2023; 37: 1350-1356

---

105026 Glaucoma Treatment and Hydrogel: Current Insights and State of the Art
Novarese C
Gels (Basel, Switzerland) 2022; 8:

---

104590 Outcomes of XEN 63 Device at 18-Month Follow-Up in Glaucoma Patients: A Two-Center Retrospective Study
Menchini M
Journal of clinical medicine 2022; 11:

---

105026 Glaucoma Treatment and Hydrogel: Current Insights and State of the Art
Caselgrandi P
Gels (Basel, Switzerland) 2022; 8:

---

104590 Outcomes of XEN 63 Device at 18-Month Follow-Up in Glaucoma Patients: A Two-Center Retrospective Study
Rossi A
Journal of clinical medicine 2022; 11:

---

104348 The current use of glaucoma virtual clinics in Europe
Michelessi M
Eye 2023; 37: 1350-1356

---

105026 Glaucoma Treatment and Hydrogel: Current Insights and State of the Art
Boscia G
Gels (Basel, Switzerland) 2022; 8:

---

104348 The current use of glaucoma virtual clinics in Europe
Fea AM
Eye 2023; 37: 1350-1356

---

104590 Outcomes of XEN 63 Device at 18-Month Follow-Up in Glaucoma Patients: A Two-Center Retrospective Study
Posarelli C; Malinverni L
Journal of clinical medicine 2022; 11:

---

104348 The current use of glaucoma virtual clinics in Europe
Oddone F; Mercieca K
Eye 2023; 37: 1350-1356

---

104590 Outcomes of XEN 63 Device at 18-Month Follow-Up in Glaucoma Patients: A Two-Center Retrospective Study
Figus M
Journal of clinical medicine 2022; 11:

---